Insider · CIK 0001811904
Judith Dunn
Files at CLYM (Climb Bio, Inc.). First filing -, latest -.
Judith Dunn files SEC Form 4 as director at CLYM (Climb Bio, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Judith Dunn has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | CLYM Climb Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jun 8, 2026 |
| Jun 4, 2025 | CLYM Climb Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jun 5, 2025 |
Questions about Judith Dunn
Answered from the filings on this page, as of the latest one.
Is Judith Dunn buying or selling?
Judith Dunn has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Judith Dunn's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Judith Dunn has 0.
Where does Judith Dunn file Form 4?
Judith Dunn has filed Form 4 at CLYM (Climb Bio, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.